当前位置: X-MOL 学术Neoplasma › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Survival of cancer patients in Fujian, Southeast China: a population-based cancer registry study.
Neoplasma ( IF 3 ) Pub Date : 2021-05-26 , DOI: 10.4149/neo_2021_210203n168
Yan Zhou 1 , Zhi-Sheng Xiang 1 , Jing-Yu Ma 1 , Yong-Tian Lin 1 , Yan-Ping Chen 2 , Hui-Juan Jiang 1 , Lin-Rong Wu 3 , Chuan-Ben Chen 4
Affiliation  

Survival rates are usually used to evaluate the effect of cancer treatment and prevention. No study has focused on the characteristic of population-based cancer survival in Fujian, which is regarded as one of the high-risk areas of cancer in China. This study aims to analyze the 5-year relative survival of patients in Fujian Province using population-based cancer registry data. A total of 8 population-based registries in Fujian Province reported cancer cases diagnosed in 2012-2014. Relative survival was calculated as the ratio between observed survival and expected survival. The 5-year relative survival for all cancers combined was 36.19% and the age-standardized 5-year relative survival for all patients was 31.80%. Females had higher relative survival than males (38.90% and 27.00%). The patients in urban areas had a higher relative survival than those in rural areas (32.34% and 31.29%). Lung, gastric, liver, colorectal, and esophageal cancers were the five most common cancers, with 5-year relative survival below 50%. This is the first study that evaluated the population-based cancer relative survival in Fujian, China. Our study suggests that the overall survival of cancer patients in Fujian Province is poor. Furthermore, the results of this study can be used as a baseline for further research in Fujian, and provide important evidence for cancer etiology research.
更新日期:2021-05-28
down
wechat
bug